Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
Andreas M Pleil,1 Feyza Darendeliler,2 Helmuth G Dörr,3 Katherine Hutchinson,4 Hartmut A Wollmann5 1Pfizer Inc., San Diego, CA, USA; 2Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, Capa, Istanbul, Turkey; 3Department of Pediatrics, University of Erlangen, Erlangen, Germany; 4Q...
Saved in:
Main Authors: | Pleil AM, Darendeliler F, Dörr HG, Hutchinson K, Wollmann HA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/e63a0ea8940446f5b99d577e65a38984 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Usability of devices for self-injection: results of a formative study on a new disposable pen injector
by: Lange J, et al.
Published: (2014) -
Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study
by: Rapaport R, et al.
Published: (2013) -
An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®
by: Estella M Davis, et al.
Published: (2010) -
Penetration Force And Cannula Sliding Profiles Of Different Pen Needles: The PICASSO Study [Erratum]
by: Leonardi L, et al.
Published: (2019) -
Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population
by: Lange J, et al.
Published: (2015)